Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen loss

BACKGROUND: Nucleos(t)ide analogs (NAs) cessation in chronic hepatitis B (CHB) patients remains a matter of debate in clinical practice. Current guidelines recommend that patients with hepatitis B e antigen (HBeAg) seroconversion discontinue NAs after relatively long-term consolidation therapy. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yan, Zhang, Meng, Li, Tao, Liu, Feng, Zhang, Li-Xin, Fan, Xiao-Ping, Yang, Bao-Hua, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047530/
https://www.ncbi.nlm.nih.gov/pubmed/33911470
http://dx.doi.org/10.3748/wjg.v27.i14.1497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047530/
https://www.ncbi.nlm.nih.gov/pubmed/33911470
http://dx.doi.org/10.3748/wjg.v27.i14.1497

Ejemplares similares